Your browser doesn't support javascript.
loading
Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report.
Zheng, Shengnan; Li, Huiying; Lin, Yongjuan; Xie, Yu; Yin, Zhenyu; Ge, Weihong; Yu, Tingting.
Afiliación
  • Zheng S; Department of Nanjing Drum Tower Hospital Clinical College of Xuzhou Medical University, Xuzhou, Jiangsu.
  • Li H; Department of Laboratory Medicine, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu.
  • Lin Y; Department of Geriatric Oncology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Xie Y; Department of Geriatric Oncology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Yin Z; Department of Geriatric Oncology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Ge W; Department of Geriatric Oncology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Yu T; Department of Laboratory Medicine, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu.
Anticancer Drugs ; 33(1): e548-e554, 2022 01 01.
Article en En | MEDLINE | ID: mdl-34321419

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinolinas / Carcinoma Adenoide Quístico / Furanos / Neoplasias de las Glándulas Anales / Indoles / Cetonas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinolinas / Carcinoma Adenoide Quístico / Furanos / Neoplasias de las Glándulas Anales / Indoles / Cetonas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article